| Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma (NCT00513604) | National Cancer Institute (NCI) | 2007-06-01 |
| VEGF Trap in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00450255) | National Cancer Institute (NCI) | 2007-06-01 |
| Bowman-Birk Inhibitor Concentrate in Healthy Men (NCT00679094) | National Cancer Institute (NCI) | 2007-06-01 |
| Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes (NCT00509496) | National Cancer Institute (NCI) | 2007-06-01 |
| Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer (NCT00509587) | National Cancer Institute (NCI) | 2007-06-01 |
| Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT00482625) | National Cancer Institute (NCI) | 2007-06-01 |
| Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors (NCT00499135) | National Cancer Institute (NCI) | 2007-05-22 |
| Radiation Exposure and Thyroid Disease in Kazakhstan (NCT00480428) | National Cancer Institute (NCI) | 2007-05-17 |
| Breast Mammogram and Tissue Study (NCT00475761) | National Cancer Institute (NCI) | 2007-05-11 |
| Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by Surgery (NCT00478140) | National Cancer Institute (NCI) | 2007-05-01 |
| Lovastatin in Treating Patients At High Risk of Melanoma (NCT00462280) | National Cancer Institute (NCI) | 2007-05-01 |
| Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00492401) | National Cancer Institute (NCI) | 2007-05-01 |
| Dasatinib in Treating Patients With Metastatic Pancreatic Cancer (NCT00474812) | National Cancer Institute (NCI) | 2007-05-01 |
| Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer (NCT00564694) | National Cancer Institute (NCI) | 2007-05-01 |
| Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma (NCT00458731) | National Cancer Institute (NCI) | 2007-05-01 |
| Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00481078) | National Cancer Institute (NCI) | 2007-05-01 |
| Pazopanib in Treating Patients With Recurrent Glioblastoma (NCT00459381) | National Cancer Institute (NCI) | 2007-05-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma (NCT00433537) | National Cancer Institute (NCI) | 2007-05-01 |
| Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT00478426) | National Cancer Institute (NCI) | 2007-04-30 |
| Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma (NCT01445340) | National Cancer Institute (NCI) | 2007-04-21 |
| MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia (NCT00462605) | National Cancer Institute (NCI) | 2007-04-01 |
| Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus (NCT00474903) | National Cancer Institute (NCI) | 2007-04-01 |
| Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer (NCT00470054) | National Cancer Institute (NCI) | 2007-04-01 |
| Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer (NCT00470301) | National Cancer Institute (NCI) | 2007-04-01 |
| Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00470470) | National Cancer Institute (NCI) | 2007-04-01 |
| Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery (NCT00459108) | National Cancer Institute (NCI) | 2007-04-01 |
| Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia (NCT00470197) | National Cancer Institute (NCI) | 2007-04-01 |
| Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments (NCT01445314) | National Cancer Institute (NCI) | 2007-03-23 |
| Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer (NCT00923377) | National Cancer Institute (NCI) | 2007-03-23 |
| Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00453154) | National Cancer Institute (NCI) | 2007-03-15 |
| Esophageal Cancer in Northeastern Iran (NCT00450788) | National Cancer Institute (NCI) | 2007-03-15 |
| Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer (NCT00468910) | National Cancer Institute (NCI) | 2007-03-01 |
| GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia (NCT00459212) | National Cancer Institute (NCI) | 2007-03-01 |
| Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors (NCT00462553) | National Cancer Institute (NCI) | 2007-03-01 |
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate (NCT00459407) | National Cancer Institute (NCI) | 2007-03-01 |
| Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer (NCT00459342) | National Cancer Institute (NCI) | 2007-03-01 |
| Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer (NCT00454363) | National Cancer Institute (NCI) | 2007-03-01 |
| 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer (NCT01445054) | National Cancer Institute (NCI) | 2007-03-01 |
| Lenalidomide and Temsirolimus in Treating Patients With Previously Treated Multiple Myeloma (NCT00398515) | National Cancer Institute (NCI) | 2007-03-01 |
| Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma (NCT00433381) | National Cancer Institute (NCI) | 2007-03-01 |
| Pazopanib in Treating Patients With Malignant Pleural Mesothelioma (NCT00459862) | National Cancer Institute (NCI) | 2007-03-01 |
| Collection of Blood From Patients With Prostate Cancer (NCT00923221) | National Cancer Institute (NCI) | 2007-02-28 |
| Safety of Batracylin in Patients With Solid Tumors and Lymphomas (NCT00450502) | National Cancer Institute (NCI) | 2007-02-24 |
| Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer (NCT00450463) | National Cancer Institute (NCI) | 2007-02-23 |
| Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers (NCT01445327) | National Cancer Institute (NCI) | 2007-02-20 |
| Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma (NCT00392444) | National Cancer Institute (NCI) | 2007-02-01 |
| Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer (NCT00450229) | National Cancer Institute (NCI) | 2007-02-01 |
| Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00429793) | National Cancer Institute (NCI) | 2007-02-01 |
| Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978) | National Cancer Institute (NCI) | 2007-02-01 |
| 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer (NCT00450619) | National Cancer Institute (NCI) | 2007-02-01 |
| Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (NCT00451048) | National Cancer Institute (NCI) | 2007-02-01 |
| Sunitinib in Treating Patients With Relapsed or Refractory Diffuse or Mediastinal Large B-Cell Lymphoma (NCT00392496) | National Cancer Institute (NCI) | 2007-02-01 |
| Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00408655) | National Cancer Institute (NCI) | 2007-02-01 |
| Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery (NCT00438464) | National Cancer Institute (NCI) | 2007-02-01 |
| Natural History Study of HIV Acquired in Infancy or Childhood (NCT00924365) | National Cancer Institute (NCI) | 2007-02-01 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (NCT00408005) | National Cancer Institute (NCI) | 2007-01-30 |
| Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer (NCT00435214) | National Cancer Institute (NCI) | 2007-01-29 |
| An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection (NCT01445145) | National Cancer Institute (NCI) | 2007-01-26 |
| Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma (NCT00423735) | National Cancer Institute (NCI) | 2007-01-24 |
| Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta (NCT00443313) | National Cancer Institute (NCI) | 2007-01-24 |
| Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation (NCT01445132) | National Cancer Institute (NCI) | 2007-01-11 |
| Evaluation of Blood Vessel Formation in Endocrine Tumors (NCT00923780) | National Cancer Institute (NCI) | 2007-01-05 |
| Aflibercept for Relapsed Multiple Myeloma (NCT00437034) | National Cancer Institute (NCI) | 2007-01-01 |
| Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00445588) | National Cancer Institute (NCI) | 2007-01-01 |
| Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery (NCT00389974) | National Cancer Institute (NCI) | 2007-01-01 |
| Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery (NCT00450879) | National Cancer Institute (NCI) | 2007-01-01 |
| Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy (NCT00381940) | National Cancer Institute (NCI) | 2007-01-01 |
| Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00388037) | National Cancer Institute (NCI) | 2007-01-01 |
| Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma (NCT00379080) | National Cancer Institute (NCI) | 2007-01-01 |
| VEGF Trap in Treating Patients With Metastatic Breast Cancer (NCT00369655) | National Cancer Institute (NCI) | 2007-01-01 |
| VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00436501) | National Cancer Institute (NCI) | 2007-01-01 |
| Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma (NCT00354107) | National Cancer Institute (NCI) | 2007-01-01 |
| Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00445549) | National Cancer Institute (NCI) | 2007-01-01 |
| Sorafenib in Treating Patients With Advanced Solid Tumors (NCT00436579) | National Cancer Institute (NCI) | 2007-01-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| Tabectedin to Treat Children and Adolescents With Cancer (NCT01453283) | National Cancer Institute (NCI) | 2006-12-20 |
| 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00288093) | National Cancer Institute (NCI) | 2006-12-20 |
| Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer (NCT00408694) | National Cancer Institute (NCI) | 2006-12-13 |
| Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer (NCT00436215) | National Cancer Institute (NCI) | 2006-12-12 |
| A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors (NCT01445106) | National Cancer Institute (NCI) | 2006-12-11 |
| Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors (NCT01445288) | National Cancer Institute (NCI) | 2006-12-05 |
| HGS-ETR2 to Treat Children With Solid Tumors (NCT00428272) | National Cancer Institute (NCI) | 2006-12-04 |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery (NCT00433576) | National Cancer Institute (NCI) | 2006-12-01 |
| 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00390052) | National Cancer Institute (NCI) | 2006-12-01 |
| Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer (NCT00416793) | National Cancer Institute (NCI) | 2006-12-01 |
| Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma (NCT00436605) | National Cancer Institute (NCI) | 2006-12-01 |
| Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00415324) | National Cancer Institute (NCI) | 2006-12-01 |
| Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma (NCT00445341) | National Cancer Institute (NCI) | 2006-11-27 |
| Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT00392353) | National Cancer Institute (NCI) | 2006-11-22 |
| Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT00416598) | National Cancer Institute (NCI) | 2006-11-15 |
| Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery (NCT00410553) | National Cancer Institute (NCI) | 2006-11-14 |
| O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy (NCT00436436) | National Cancer Institute (NCI) | 2006-11-13 |
| Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer (NCT00390325) | National Cancer Institute (NCI) | 2006-11-03 |
| Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00337077) | National Cancer Institute (NCI) | 2006-11-01 |
| Diindolylmethane in Healthy Volunteers (NCT00392652) | National Cancer Institute (NCI) | 2006-11-01 |
| Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine (NCT00397787) | National Cancer Institute (NCI) | 2006-11-01 |
| Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer (NCT00408902) | National Cancer Institute (NCI) | 2006-11-01 |
| AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer (NCT00397878) | National Cancer Institute (NCI) | 2006-11-01 |
| E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00400829) | National Cancer Institute (NCI) | 2006-11-01 |
| Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma (NCT00410605) | National Cancer Institute (NCI) | 2006-11-01 |